Outset Medical Inc. Common Stock (OM)

About OM

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumabl…

Sector

Health Care

Industry

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Employees

310

Website

outsetmedical.com/

Fundamentals

1-day range

$3.91$4.18

Market cap

$96.39M

P/E (trailing)

—

P/E (forward)

-1.72

EPS (trailing)

$-4.15

Dividend yield

—

Beta

2.00

Avg. volume

204.0K

Forecasts

3 analyst ratings

Outset Medical Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• OM

  Outset Medical Inc. Common Stock

  $3.93

  ▼ 4.03%
  Market cap $96.39MP/E —
  $3$16.16
• HYPR

  Hyperfine Inc. Class A Common Stock

  $0.8358

  ▼ 1.09%
  Market cap $97.48MP/E —
• HSDT

  Solana Company Class A Common Stock (DE)

  $2.34

  ▼ 3.70%
  Market cap $98.09MP/E —
  $1.19$25.5
• NRXS

  Neuraxis Inc. Common Stock

  $5.98

  ▼ 0.66%
  Market cap $86.47MP/E —
  $2.21$9.33
• STEX

  Streamex Corp. Common Stock

  $0.7649

  ▼ 7.51%
  Market cap $75.35MP/E —
  $0.6552$7.44
• POCI

  Precision Optics Corporation Inc. Common stock

  $4.41

  ▼ 0.45%
  Market cap $46.41MP/E —
  $3.55$6.15
• QTI

  QT Imaging Holdings Inc. Common Stock

  $3.09

  ▼ 0.96%
  Market cap $37.38MP/E —
  $2.62$19.05

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Outset Medical, Inc. (OM) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/7/2026
• Outset Medical (NASDAQ:OM) Jumps 19% on Q2 Revenue Beat, HCA Deal
  ChartMill · 8/6/2026
• Outset Medical Affirms FY2026 Sales Guidance of $125.000M-$130.000M vs $126.633M Est
  Benzinga · 8/6/2026
• Outset Medical Q2 Adj. EPS $(0.80) Misses $(0.72) Estimate, Sales $31.635M Beat $29.833M Estimate
  Benzinga · 8/6/2026

• Karen Prange · June 4, 2026 · Grant

  10.7K
• Brent D. Lang · June 4, 2026 · Grant

  10.7K
• Karen Drexler · June 4, 2026 · Grant

  10.7K
• Patrick T. Hackett · June 4, 2026 · Grant

  10.7K
• D. Keith Grossman · June 4, 2026 · Grant

  10.7K
• Kevin C. Oboyle · June 4, 2026 · Grant

  10.7K
• Renee Gaeta · June 3, 2026 · Sale

  17.7K @ $4.94
• Marc Nash · May 15, 2026 · Sale

  1.6K @ $3.7
• John L. Brottem · May 15, 2026 · Sale

  2.6K @ $3.7
• Leslie Trigg · May 15, 2026 · Sale

  3.4K @ $3.7
• Braden Michael Leonard · May 15, 2026 · X

  323.0K @ $5
• Braden Michael Leonard · May 11, 2026 · X

  96.9K @ $5
• Braden Michael Leonard · May 8, 2026 · X

  197.6K @ $5
• Derick A. Elliott · April 6, 2026 · Grant

  96.0K

Institutional Ownership

March 31, 2026

Total shares held

15.20M

Total value held

$57.99M

Institutional holders

93